Found 54 matching trials
Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer PHASE2 The present investigation aims to evaluate the efficacy of an innovative pr...
Show More Location
Hôpital Antoine Béclère
Learn More & Join Trial
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer PHASE3 This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Show More Location
The Mayo Clinic - Phoenix
Learn More & Join Trial
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer PHASE2 Asymptomatic patients with metastatic castrate resistant prostate cancer (m...
Show More Location
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function NA Complaints about memory and thinking are common in women as they go through...
Show More Location
University of Colorado Anschutz Medical Campus
Learn More & Join Trial
A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer N/A This is an observational study in which patient data from the past on men w...
Show More Learn More & Join Trial
Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer EARLY_PHASE1 The purpose of this study is to see whether immunotherapy with BMS-986218 a...
Show More Location
Columbia University Irving Medical Center
Learn More & Join Trial
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT PHASE2 The purpose of this research study is to test the efficacy of ADT on prosta...
Show More Location
Miami Cancer Institute at Baptist Health, Inc.
Learn More & Join Trial
A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy PHASE2 This phase II trial studies how well apalutamide, abiraterone acetate, pred...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response PHASE2 The objective of this study is to determine the safety and clinical effects...
Show More Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer PHASE2 The primary objective is to determine the safety and activity of combined h...
Show More Status
Active Not Recruiting
Location
Columbia University Irving Medical Center
Learn More & Join Trial